H-TevBmo variants bind and cleave TevBmoHS substrate by Qingqing Liu (15909)

Dynamic changes in physic-chemical properties and bacterial community during natural fermentation of tomatoes by Xiaoli ZHOU (10466500)

Small ruminant lentiviruses: economic and productive losses, consequences of the disease by Dalva Alana Aragão de Azevedo (5833607)

The Effect of Electropulsing Treatment on Properties of Pre-compressed AZ31 Magnesium Alloy by Xing-xiao Zhu (8590350)

Study of the use of expanded vermiculite in the mechanical properties of light mortars by Deize Daiane Pinto Guilherme (10472606)

Contrasting responses after fires of the source components of soil respiration and ecosystem respiration by JI CHEN (5018072)

Temporal and spatial patterns of hydroclimate variability related to the Pacific Decadal Oscillation in Michigan, USA by Todd Grote (17972316)

Evaluation of the effects of diode laser application on experimental orthodontic tooth movements in rats. Histopathological analysis by Mehmet Ali Karabel (10394369)

The effect of process parameters on the quality of needle-punched nonwoven components used in the automotive industry. by Nontsikelelo Dumakude (13114023)

Image_1_T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.tif by Lirong Wu (3512831)

“…All patients received definitive SBRT to a biologically effective dose of >=100 Gy. The number of unique TCR clones was decreased after SBRT versus before, but clonality and the Shannon Entropy did not change. …”

Image_4_T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.tif by Lirong Wu (3512831)

“…All patients received definitive SBRT to a biologically effective dose of >=100 Gy. The number of unique TCR clones was decreased after SBRT versus before, but clonality and the Shannon Entropy did not change. …”

Image_3_T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.tif by Lirong Wu (3512831)

“…All patients received definitive SBRT to a biologically effective dose of >=100 Gy. The number of unique TCR clones was decreased after SBRT versus before, but clonality and the Shannon Entropy did not change. …”

Image_2_T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.tif by Lirong Wu (3512831)

“…All patients received definitive SBRT to a biologically effective dose of >=100 Gy. The number of unique TCR clones was decreased after SBRT versus before, but clonality and the Shannon Entropy did not change. …”

Table_1_T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.docx by Lirong Wu (3512831)

“…All patients received definitive SBRT to a biologically effective dose of >=100 Gy. The number of unique TCR clones was decreased after SBRT versus before, but clonality and the Shannon Entropy did not change. …”

Genome-wide complementary agonist and antagonist screens of host-encoded miRNAs impacting henipavirus infection at BSL-4. by Chwan Hong Foo (2571913)

“…(B and C) Results from the miRNA agonist (B) and antagonist (C) screens, with miRNAs ranked using a robust Z-score approach, from lowest (decreased virus infection) to highest (increased virus infection). …”

Antiviral effect of compounds on bunyavirus replication. by Elizabeth Geerling (9566942)

DataSheet_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.docx by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Image_3_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

“…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10⁹ cells and a dose-climbing strategy. …”

Two residues (-18β and β57) in the HLA-DQ heterodimer were critically associated with progression from islet autoimmunity to diabetes in the DPT-1 trial. by Lue Ping Zhao (7456202)